All Articles

Replenish Nutrients is partnering with Hutterite colonies to build a decentralized production network. Is this a new model for capital-light industrial growth?

The Museum of American Finance's move from Wall Street to Boston is a strategic play on accessibility, technology, and the city's rising influence.

A landmark deal brings VIZZ, a once-daily presbyopia treatment, to Australia and New Zealand, promising millions a life with less reliance on reading glasses.

Vantor and BAE Systems are building next-gen 20cm satellites. We analyze if this leap in resolution will truly redefine spatial intelligence or just raise the stakes.

Apollo Commercial Real Estate's large dividend has activated a special NYSE rule. We break down what the 'due bill' period means for shareholders and market mechanics.

A new board appointment reveals Serve Robotics' grand plan: to evolve from a delivery bot company into a foundational robotics infrastructure provider.

A routine press release from Pyxis Tankers about a safe transit reveals the untold story of navigating a post-war chokepoint and a new era of global risk.

A new partnership between Koop Technologies and ViaLinx.io aims to end the war between uptime and compliance, creating a unified framework for the digital age.

With speakers from OpenAI and Google, The AI Conference focuses on practical strategies for operationalizing AI, moving the industry from promise to production.

Bionano Genomics brings back OGM pioneer Dr. Alex Hastie as CSO. It's a strategic move to accelerate clinical adoption and restore investor confidence.

The mining giant’s dividend boost isn't just a shareholder reward; it's a bold signal of confidence in a supercharged copper market. What's the story here?

A new partnership between Circadence and Scale AI aims to move AI from the lab to the front lines of cyber defense, promising a new era of autonomous readiness.

With quantum attacks looming, SEALSQ warns Europe's digital infrastructure is at risk. A deep dive into the race to build a quantum-proof future.

Oxford's Ludovic Phalippou has been honored for his critical research demystifying private markets. His work challenges performance myths and fee opacity.

Beyond batteries, BLUETTI bets on open standards and AI partnerships to redefine energy independence. Is this the blueprint for the smart home grid?

REPROCELL's submission for Stemchymal® offers hope for an incurable disease and highlights Japan's accelerated regulatory path for regenerative medicine.

As automation floods the ad world, Bottle Rocket Media's handcrafted anniversary campaign argues that human creativity delivers an ROI that algorithms can't match.

A deep dive into KNAV's WPO recognition reveals a new blueprint for success in professional services: global integration, AI-first strategy, and diverse leadership.

State Street's new Nasdaq-100 ETF, QNDX, enters the ring with a rock-bottom fee, challenging titans like QQQ and reshaping core growth investing.

A new RNA therapy for obesity is advancing in trials. It promises to reduce harmful visceral fat, preserve muscle, and may only require a twice-yearly dose.